Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 2
2008 6
2009 12
2010 15
2011 14
2012 7
2013 11
2014 14
2015 11
2016 10
2017 19
2018 14
2019 19
2020 15
2021 17
2022 10
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Sigma receptor and aquaporin modulators: chiral resolution, configurational assignment, and preliminary biological profile of RC752 enantiomers.
Listro R, Marra A, Cavalloro V, Rossino G, Linciano P, Rossi D, Casali E, De Amici M, Mazzeo G, Longhi G, Fusè M, Dondio G, Pellavio G, Laforenza U, Schepmann D, Wünsch B, Collina S. Listro R, et al. Among authors: schepmann d. J Pharm Biomed Anal. 2024 Feb 15;239:115902. doi: 10.1016/j.jpba.2023.115902. Epub 2023 Dec 14. J Pharm Biomed Anal. 2024. PMID: 38101238 Free article.
Downstream Allosteric Modulation of NMDA Receptors by 3-Benzazepine Derivatives.
Ritter N, Disse P, Aymanns I, Mücher L, Schreiber JA, Brenker C, Strünker T, Schepmann D, Budde T, Strutz-Seebohm N, Ametamey SM, Wünsch B, Seebohm G. Ritter N, et al. Among authors: schepmann d. Mol Neurobiol. 2023 Dec;60(12):7238-7252. doi: 10.1007/s12035-023-03526-1. Epub 2023 Aug 5. Mol Neurobiol. 2023. PMID: 37542648 Free PMC article.
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain.
Rossino G, Marra A, Listro R, Peviani M, Poggio E, Curti D, Pellavio G, Laforenza U, Dondio G, Schepmann D, Wünsch B, Bedeschi M, Marino N, Tesei A, Ha HJ, Kim YH, Ann J, Lee J, Linciano P, Di Giacomo M, Rossi D, Collina S. Rossino G, et al. Among authors: schepmann d. Pharmaceuticals (Basel). 2023 Jul 5;16(7):962. doi: 10.3390/ph16070962. Pharmaceuticals (Basel). 2023. PMID: 37513874 Free PMC article.
Conformationally Restricted σ1 Receptor Antagonists from (-)-Isopulegol.
Blicker L, González-Cano R, Laurini E, Nieto FR, Schmidt J, Schepmann D, Pricl S, Wünsch B. Blicker L, et al. Among authors: schepmann d. J Med Chem. 2023 Apr 13;66(7):4999-5020. doi: 10.1021/acs.jmedchem.2c02081. Epub 2023 Mar 22. J Med Chem. 2023. PMID: 36946301
Correction to "Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease".
Turgutalp B, Bhattarai P, Ercetin T, Luise C, Reis R, Gurdal EE, Isaak A, Biriken D, Dinter E, Sipahi H, Schepmann D, Junker A, Wünsch B, Sippl W, Gulcan HO, Kizil C, Yarim M. Turgutalp B, et al. Among authors: schepmann d. J Med Chem. 2023 Jan 26;66(2):1652. doi: 10.1021/acs.jmedchem.2c02094. Epub 2023 Jan 18. J Med Chem. 2023. PMID: 36651752 No abstract available.
Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol - starting point for PET tracer development.
Korff M, Steigerwald R, Bechthold E, Schepmann D, Schreiber JA, Meuth SG, Seebohm G, Wünsch B. Korff M, et al. Among authors: schepmann d. Biol Chem. 2022 Oct 10;404(4):279-289. doi: 10.1515/hsz-2022-0222. Print 2023 Mar 28. Biol Chem. 2022. PMID: 36215695
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease.
Turgutalp B, Bhattarai P, Ercetin T, Luise C, Reis R, Gurdal EE, Isaak A, Biriken D, Dinter E, Sipahi H, Schepmann D, Junker A, Wünsch B, Sippl W, Gulcan HO, Kizil C, Yarim M. Turgutalp B, et al. Among authors: schepmann d. J Med Chem. 2022 Sep 22;65(18):12292-12318. doi: 10.1021/acs.jmedchem.2c01003. Epub 2022 Sep 9. J Med Chem. 2022. PMID: 36084304
178 results